Skip to content

Clinical trials

Phase 1 RNA Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: RNA Virus Infections Phase: Phase 1 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20143
20162
20181
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emergent BioSolutions2
Arbutus Biopharma Corporation1
City of Hope Medical Center1
Gilead Sciences1
ModernaTX, Inc.1
National Institute of Allergy and Infectious Diseases (NIAID)1
SRI International1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
RNA Virus Infections8
Virus Diseases7
Flaviviridae Infections3
Hemorrhagic Fevers, Viral3
Arbovirus Infections2
Dengue2
Flavivirus Infections2
HIV Infections2
Immune System Diseases2
Immunologic Deficiency Syndromes2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.